| Phase 12 trials |
|
Phase 1
|
NCT07078695 |
Aug 2025 → Sep 2026 overdue |
psoriasis |
Atridia Pty Ltd. |
Active not recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT07051538 |
Jun 2024 → Nov 2025 |
psoriasis |
Guangdong Hengrui Pharmaceutical Co., Ltd |
Completed
|
No outcome recorded
|
| Phase 24 trials |
|
Phase 2
|
NCT07444684 |
Mar 2026 → Jun 2027 expected |
pyoderma gangrenosum |
Guangdong Hengrui Pharmaceutical Co., Ltd |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07337564 |
Feb 2026 → Dec 2027 expected |
pyoderma gangrenosum |
Shandong First Medical University |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07232576 |
Dec 2025 → Aug 2027 expected |
— |
Guangdong Hengrui Pharmaceutical Co., Ltd |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06875934 |
Mar → Nov 2025 overdue |
psoriasis |
Guangdong Hengrui Pharmaceutical Co., Ltd |
Active not recruiting
|
No outcome recorded
|